Vassili Soumelis

Title: Vassili Soumelis: Innovator in Cytokine Research

Introduction

Vassili Soumelis is a prominent inventor based in Paris, France. He has made significant contributions to the field of cytokine research, holding a total of 4 patents. His work focuses on the development of antibodies and methods related to cytokines, which are crucial for understanding and treating various diseases.

Latest Patents

Soumelis's latest patents include innovative approaches to cytokine research. One of his notable patents involves antibodies to IL-B50, which includes purified genes encoding cytokines from mammals. This patent provides reagents such as purified proteins, specific antibodies, and nucleic acids encoding this molecule. Additionally, methods of using these reagents and diagnostic kits are also outlined. Another significant patent details a method of treatment using an anti-IL-B50 antibody, which includes nucleic acids encoding mammalian cytokine receptors, purified proteins, and fragments thereof. This patent also describes methods for both diagnostic and therapeutic utilities.

Career Highlights

Throughout his career, Vassili Soumelis has worked with leading pharmaceutical companies, including Schering Corporation and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

Soumelis has collaborated with notable scientists in his field, including Yong-Jun Liu and Rene De Waal Malefyt. These collaborations have further enriched his research and expanded the impact of his work in cytokine studies.

Conclusion

Vassili Soumelis is a distinguished inventor whose work in cytokine research has led to valuable patents and advancements in medical science. His contributions continue to influence the development of diagnostic and therapeutic methods in the field.